Related Experiment Video
Updated: Aug 21, 2025

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
Renal dysfunction and outcome in left ventricular non-compaction
Ladina Erhart1, Beat A Kaufmann2, Baris Gencer3,4
1Department of Cardiology, University Heart Center Zurich, Switzerland. ladinaerhart@gmail.com.
Insights
Impaired kidney function in patients with left ventricular non-compaction cardiomyopathy (LVNC) significantly increases the risk of death or heart transplantation. Routine renal function assessment is crucial for risk stratification in LVNC patients.
Area of Science:
- Cardiology
- Nephrology
- Biomedical Research
Background:
- Renal function's impact on clinical outcomes is known in other cardiomyopathies, but its prognostic value in left ventricular non-compaction cardiomyopathy (LVNC) remains uninvestigated.
- Assessing renal function's role in LVNC prognosis is critical for improving patient management.
Purpose of the Study:
- To determine the prognostic significance of renal function in patients diagnosed with LVNC.
- To evaluate the association between renal function markers and adverse clinical outcomes in LVNC.
Main Methods:
- Retrospective analysis of isolated LVNC patients diagnosed via echocardiography and/or MRI across four Swiss centers.
- Collection of creatinine, urea, and estimated glomerular filtration rate (eGFR) values using the CKD-EPI 2009 formula.
- Application of Cox regression modeling to assess the composite endpoint of death or heart transplantation.
Main Results:
- A significant association was found between impaired renal function and increased risk of death or heart transplantation in LVNC patients.
- Elevated creatinine and urea levels, and decreased eGFR were independently linked to adverse outcomes.
- Hazard ratios indicated a substantial increase in risk for each increment/decrement in renal function parameters.
Conclusions:
- Impairment in renal function is a significant predictor of adverse outcomes, including death and heart transplantation, in patients with LVNC.
- Kidney function assessment should be integrated into the standard risk assessment protocols for LVNC patients.
- This study highlights the importance of a multidisciplinary approach in managing LVNC.
Background:
While renal function has been observed to inversely correlate with clinical outcome in other cardiomyopathies, its prognostic significance in patients with left ventricular non-compaction cardiomyopathy (LVNC) has not been investigated. The aim of this study was to determine the prognostic value of renal function in LVNC patients.
Methods:
Patients with isolated LVNC as diagnosed by echocardiography and/or magnetic resonance imaging in 4 Swiss centers were retrospectively analyzed for this study. Values for creatinine, urea, and estimated glomerular filtration rate (eGFR) as assessed by the CKD-EPI 2009 formula were collected and analyzed by a Cox regression model for the occurrence of a composite endpoint (death or heart transplantation).
Results:
During the median observation period of 7.4 years 23 patients reached the endpoint. The ageand gender-corrected hazard ratios (HR) for death or heart transplantation were: 1.9 (95% confidence interval [CI] 1.4-2.6) for each increase over baseline creatinine level of 30 μmol/L (p < 0.001), 1.6 (95% CI 1.2-2.2) for each increase over baseline urea level of 5 mmol/L (p = 0.004), and 3.6 (95% CI 1.9-6.9) for each decrease below baseline eGFR level of 30 mL/min (p ≤ 0.001). The HR (log2) for every doubling of creatinine was 7.7 (95% CI 3-19.8; p < 0.001), for every doubling of urea 2.5 (95% CI 1.5-4.3; p < 0.001), and for every bisection of eGFR 5.3 (95% CI 2.4-11.6; p < 0.001).
Conclusions:
This study provides evidence that in patients with LVNC impairment in renal function is associated with an increased risk of death and heart transplantation suggesting that kidney function assessment should be standard in risk assessment of LVNC patients.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
07:24Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Pathophysiology of Heart Failure
Mitral Regurgitation I: Introduction